You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

advanced osteosarcoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Osteosarcoma Trial (Tucidinostat, Apatinib)

Not yet recruiting
  • Osteosarcoma
  • Tucidinostat, Apatinib
  • (no location specified)
Nov 5, 2023

Advanced Renal Cell Carcinoma, Advanced Mesothelioma, Advanced Osteosarcoma Trial in Houston (CAR.70/IL15-transduced CB-derived

Not yet recruiting
  • Advanced Renal Cell Carcinoma
  • +2 more
  • CAR.70/IL15-transduced CB-derived NK cells
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)

Not yet recruiting
  • Cancer
  • +6 more
  • KB707
  • (no location specified)
Jul 24, 2023

Solid Tumor, Adult, Triple Negative Breast Cancer, Colorectal Cancer Trial in Scottsdale, La Jolla, Stanford (CRX100 suspension

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • CRX100 suspension for infusion
  • Scottsdale, Arizona
  • +2 more
Jul 26, 2022

Solid Tumors, Lung Adenocarcinoma, Osteosarcoma Trial in Tianjin (IBI188, GM-CSF, Cisplatin/Carboplatin)

Terminated
  • Solid Tumors
  • +2 more
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 3, 2022

Sarcoma,Soft Tissue Trial in Barcelona, Madrid, Zaragoza (Selinexor)

Recruiting
  • Sarcoma,Soft Tissue
  • Barcelona, Spain
  • +5 more
Nov 16, 2021

Pancreatic Cancer, Osteosarcoma, MPNST (Malignant Peripheral Nerve Sheath Tumor) Trial in Santa Monica (DeltaRex-G)

Available
  • Pancreatic Cancer
  • +6 more
  • Santa Monica, California
    Sarcoma Oncology Research Center, LLC
Jan 20, 2022

Soft Tissue Sarcoma, Bone Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate, Gemcitabine)

Not yet recruiting
  • Soft Tissue Sarcoma
  • +5 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Sep 16, 2022

Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)

Not yet recruiting
  • Soft Tissue Sarcoma
  • Bone Sarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Nov 10, 2022

Soft-tissue Sarcoma, Osteosarcoma, Chordoma Trial in Spain (Palbociclib)

Recruiting
  • Soft-tissue Sarcoma
  • +2 more
  • Barcelona, Spain
  • +18 more
May 30, 2022

Solid Tumor, Osteosarcoma Trial in Bordeaux, Lille, Lyon (Sirolimus combined with CP, MT and ZA)

Recruiting
  • Solid Tumor
  • Osteosarcoma
  • Sirolimus combined with CP, MT and ZA
  • Bordeaux, France
  • +2 more
May 4, 2021

Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma Trial in United States (Abemaciclib)

Recruiting
  • Chondrosarcoma
  • +2 more
  • Jacksonville, Florida
  • +3 more
Apr 4, 2022

Osteosarcoma, Neuroblastoma, Gastric Cancer Trial (Targeting CD276 CAR T cells)

Not yet recruiting
  • Osteosarcoma
  • +3 more
  • Targeting CD276 CAR T cells
  • (no location specified)
Apr 30, 2021

Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

Withdrawn
  • Soft Tissue Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Nov 30, 2021

Sarcoma, Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate)

Recruiting
  • Sarcoma
  • +4 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Feb 9, 2022

Effect of Drugs, Progression, Pediatric Cancer Trial in Beijing (Famitinib, Ifosfamide, Camrelizumab)

Withdrawn
  • Effect of Drugs
  • +2 more
  • Beijing, Beijing, China
    Lu Xie
May 15, 2020

Progression-free Survival, Overall Survival, Clinical Benefit Rate Trial in Beijing (Apatinib, SHR-1210)

Completed
  • Progression-free Survival
  • +3 more
  • Beijing, China
  • +1 more
May 15, 2020

Safety Issues, Efficacy, Self Trial in Beijing (TQB3525)

Active, not recruiting
  • Safety Issues
  • Efficacy, Self
  • Beijing, China
    Peking University Shougang Hospital
Dec 29, 2020

Osteosarcoma, Neuroblastoma Trial in Houston (genetic, biological, drug)

Active, not recruiting
  • Osteosarcoma
  • Neuroblastoma
  • GD2 T cells
  • +3 more
  • Houston, Texas
  • +1 more
Apr 16, 2021

Breast Cancer, Colorectal Cancer, Adenoid Cystic Carcinoma Trial in Worldwide (CB-103)

Recruiting
  • Breast Cancer
  • +7 more
  • Santa Monica, California
  • +19 more
Jan 6, 2022

Drug Resistance to Famitinib and Camrelizumab, Biomarkers for Efficacy and Toxicity Trial in Beijing (5hmc testing)

Unknown status
  • Drug Resistance to Famitinib and Camrelizumab
  • Biomarkers for Efficacy and Toxicity
  • 5hmc testing
  • Beijing, Beijing, China
    Peking University People's Hospital
Feb 4, 2020

Soluble B7-H3 as a Biomarker for Osteosarcoma

Recruiting
  • Biomarker
  • +3 more
  • ELISA: enzyme-linked immunosorbent assay
  • Beijing, Beijing, China
    Peking University People's Hospital
Jul 5, 2023

Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer Trial in Worldwide (CC-115)

Completed
  • Glioblastoma Multiforme
  • +5 more
  • Los Angeles, California
  • +16 more
Oct 4, 2021

Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

Recruiting
  • Adenocarcinoma
  • +75 more
  • Biomarker Testing (L)
  • +2 more
  • Idaho Falls, Idaho
  • +1 more
Oct 18, 2022

Soft Tissue Sarcoma, Bone Sarcoma Trial in Italy, Spain, United Kingdom (Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Nivolumab

Recruiting
  • Soft Tissue Sarcoma
  • Bone Sarcoma
  • Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]
  • +7 more
  • Bologna, Italy
  • +12 more
Nov 10, 2021